Cancer drug shortage: What you should know

October 17, 2019

A drug used to treat children and animals with cancer is getting harder to find after one pharmaceutical company announced it would stop making it.

Spotlight

Ferrosan Medical Devices A/S

Ferrosan Medical Devices provides a range of innovative medical devices. Our focus is centered on haemostasis during surgery, regional anaesthesia and biopsy. Ferrosan Medical Devices consists of two entities: Biomaterials & Electromechanics. Biomaterials develops and manufactures advanced topical haemostatic products to control bleeding in surgery. The products are marketed in more than 100 countries around the globe via Ethicon Biosurgery, a Johnson & Johnson Company. In addition, selected countries and segments are served by Takeda, Sanofi-Aventis and Elanco Animal Health.

OTHER VIDEOS

Welcome to the Azelis Pharma lab in Paris, France!

video | January 30, 2023

As a leading global innovation service provider in the specialty chemicals and food ingredients industry, we are committed to creating value for principals and customers whilst providing a great work environment and career opportunities....

Watch Now

Daikyo Crystal Zenith® Insert Needle Syringe

video | January 27, 2023

The Daikyo Crystal Zenith® Insert Needle Syringe system was designed to maintain purity, integrity and efficacy of premium biopharmaceutical therapies....

Watch Now

Little Green Pharma continues to expand making significant strides

video | January 31, 2023

Leading Australian medicinal cannabis exporter, Little Green Pharma continues to expand making significant strides in lucrative global markets...

Watch Now

Teva Expands Partnership to Bring Critical Medicines to Children Living with Cancer

video | January 26, 2023

Teva believes medicine should always be accessible, and we work to help make this a reality. We're working with Global HOPE (Hematology Oncology Pediatric Excellence), a non-profit...

Watch Now

Spotlight

Ferrosan Medical Devices A/S

Ferrosan Medical Devices provides a range of innovative medical devices. Our focus is centered on haemostasis during surgery, regional anaesthesia and biopsy. Ferrosan Medical Devices consists of two entities: Biomaterials & Electromechanics. Biomaterials develops and manufactures advanced topical haemostatic products to control bleeding in surgery. The products are marketed in more than 100 countries around the globe via Ethicon Biosurgery, a Johnson & Johnson Company. In addition, selected countries and segments are served by Takeda, Sanofi-Aventis and Elanco Animal Health.

Events